🔔 Please share, @BHAcademics is recruiting for a PGY2 infectious diseases pharmacy resident.
🤩 9 BCIDP preceptors. 9 preceptors with PGY2 training in ID. Attendance at IDweek, MAD-ID, ASHP MCM, and ECCMID. Exposure to a system with 12 hospitals, >100 outpatient centers, home infusion, infusion centers, community pharmacy, and so much more. I hear the RPD isn’t bad either.
📱Find it at PPS & learn more: https://t.co/pBhhNq4gkY #IDxPosts #TwitteRx
Thank GOD, thank GOD! I just got my Flu shot and COVID-19 Booster Vaccine! I feel great, thanks again to all the Doctors and Nurses on the front line! #stayinghealthy#IPityTheFool
👋 If you are at #MADID2023 come stop by the posters on Thursday and say hi to @LOUvofloxacin who will be presenting her fantastic residency project looking at what happens when you stop reporting ESBL results.
#TwitteRx#MedTwitter#IDtwitter
Couldn't tweet while giving my own talk on Outpatient Antimicrobial Stewardship this afternoon, so figured would share a few slides now.
#SHEASpring2022
🧵
1/
OFID: Among MRSA bacteremic patients, vancomycin-associated acute kidney injury increased as a function of the day 2 area under the curve, even for daily AUCs within the recommended therapeutic range.
📄:https://t.co/il1clUZ8sj
#IDSAJournals@PaulSaxMD@DrJLi @lodisetom
1/ For #TxID and ID specialists who see patients at high risk for fungal infections, this table summarizing late-stage and new antifungal agents is terrific:
Anybody who says "I hate Twitter" has never tried to keep up with a pandemic in which crucial new data is released every few hours, data that often requires sophisticated interpretation by domain experts in areas ranging from virology to epidemiology to supply chain to sociology.
Compared with unvaccinated persons, persons vaccinated before and up to 12 weeks after a #COVID19 diagnosis had a 78% lower odds of #LongCovid (OR 0.220) #vaccine https://t.co/opMkn0Yh4n